JPWO2021112235A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021112235A5
JPWO2021112235A5 JP2021562750A JP2021562750A JPWO2021112235A5 JP WO2021112235 A5 JPWO2021112235 A5 JP WO2021112235A5 JP 2021562750 A JP2021562750 A JP 2021562750A JP 2021562750 A JP2021562750 A JP 2021562750A JP WO2021112235 A5 JPWO2021112235 A5 JP WO2021112235A5
Authority
JP
Japan
Prior art keywords
peptide
adrenomedullin
amino acid
acid sequence
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021562750A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021112235A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/045294 external-priority patent/WO2021112235A1/ja
Publication of JPWO2021112235A1 publication Critical patent/JPWO2021112235A1/ja
Publication of JPWO2021112235A5 publication Critical patent/JPWO2021112235A5/ja
Pending legal-status Critical Current

Links

JP2021562750A 2019-12-05 2020-12-04 Pending JPWO2021112235A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019220002 2019-12-05
PCT/JP2020/045294 WO2021112235A1 (ja) 2019-12-05 2020-12-04 C3腎症を予防又は治療するための医薬、医薬組成物及び補体C3b分解促進剤

Publications (2)

Publication Number Publication Date
JPWO2021112235A1 JPWO2021112235A1 (https=) 2021-06-10
JPWO2021112235A5 true JPWO2021112235A5 (https=) 2022-08-01

Family

ID=76221743

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021562750A Pending JPWO2021112235A1 (https=) 2019-12-05 2020-12-04

Country Status (2)

Country Link
JP (1) JPWO2021112235A1 (https=)
WO (1) WO2021112235A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106164088B (zh) * 2014-03-20 2021-11-23 国立大学法人宫崎大学 长效肾上腺髓质素衍生物
SG10202111663PA (en) * 2017-02-27 2021-12-30 Regeneron Pharma Humanized model of kidney and liver disorders

Similar Documents

Publication Publication Date Title
AU2001273388B2 (en) "Pseudo"-native chemical ligation
EP1263471B1 (en) Antimicrobial compounds and formulations
JP4067058B2 (ja) Peg化hgf
US20080318849A1 (en) Kahalalide F and Related Compounds
JPWO1996028475A1 (ja) Peg化hgf
CA2192787A1 (en) Pth or pthrp antagonists
MX2011005363A (es) Peptidos para inhibicion del factor alfa de necrosis tumoral y usos de los mismos.
JPWO2021112235A5 (https=)
JP3274225B2 (ja) アミノ酸誘導体及びその用途
JPH03120297A (ja) 抗凝固ペプチド
CN1041157A (zh) 肽醇抗血凝剂
CN1119650A (zh) 具有胃肠道运动刺激活性的胃动素样多肽
AR134636A1 (es) Compuestos peptídicos híbridos que tienen un residuo de lisina modificado
WO2007095659A1 (de) Peptide und peptid-derivate, herstellun derselben sowie deren verwendung zur herstellung eines therapeutisch und/oder präventiv wirkenden arzneimittels
JPH05508850A (ja) 抗凝固ペプチド
JPWO2021112220A5 (https=)
JPH0769915A (ja) ウィルス感染・増殖抑制剤
JP3190765B2 (ja) ペプチド誘導体及びその用途
CA2362525A1 (en) Cyclic peptides and aids vaccines
TW202511281A (zh) 抗病毒多肽類似物
KR20250094725A (ko) Ccr2 억제제 및 사용 방법
WO2025043696A1 (zh) 抗病毒多肽类似物
US5502164A (en) Peptide compounds having therapeutic activity
JP4188897B2 (ja) ウィルス感染・増殖抑制剤
HK40100630A (zh) 抗病毒多肽类似物